Results of a meta-analysis reveal significant reductions in blood pressure and heart rate.
In their meta-analysis of grape seed extract and heart health factors, researchers from the University of Connecticut and Yale University say that grape seed extract appears to lower blood pressure and heart rate in human subjects. The work has been published in the Journal of the American Dietetic Association.
Database searches on trials investigating grape seed extract supplementation and heart health factors including blood pressure, heart rate, and cholesterol yielded nine studies (390 subjects) fit for meta-analysis.
Results of the meta-analysis revealed significant reductions in blood pressure (-1.54 mm Hg) and heart rate (-1.42 bpm). These changes may seem small, but lead author Craig Coleman of the University of Connecticut stresses that a little change can go a long way:
The level of systolic blood pressure reduction is very modest in comparison to reductions seen with prescription antihypertensive drugs. However, this modest effect may still be noteworthy on a population basis. It has been estimated that every 3 mm Hg reduction in systolic blood pressure could reduce the risk of all-cause mortality by 4%, mortality after stroke by 8% and mortality after coronary artery disease by 5%.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.